Bristol Consumer Unit Suitors Tasked With Determining Value Of Excedrin
This article was originally published in The Tan Sheet
Executive Summary
Bristol-Myers Squibb says it will contact potential buyers for its North American Consumer Medicines division "over the coming weeks.
You may also be interested in...
Novartis Purchase Of Bristol OTCs Has Excedrin Written All Over It
Novartis will enter the U.S. over-the-counter analgesics market with Excedrin as part of the purchase of Bristol-Myers Squibb's OTC portfolio
Novartis Purchase Of Bristol OTCs Has Excedrin Written All Over It
Novartis will enter the U.S. over-the-counter analgesics market with Excedrin as part of the purchase of Bristol-Myers Squibb's OTC portfolio
Novartis Purchase Of Bristol OTCs Has Excedrin Written All Over It
Novartis will enter the U.S. over-the-counter analgesics market with Excedrin as part of the purchase of Bristol-Myers Squibb's OTC portfolio